Actively Recruiting
Determining Individualized Cancer Therapy in Pancreatic Cancer
Led by Medical College of Wisconsin · Updated on 2026-05-05
1000
Participants Needed
1
Research Sites
504 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a non-therapeutic exploratory observational precision oncology study designed to collect and analyze data that demonstrate the clinical efficacy and tolerability of personalized treatments based on molecular tumor profiling assessments (i.e., matched therapy) in adult pancreatic cancer patients. Patient medical records, obtained both retrospectively and prospectively, will be examined for results of molecular profiling obtained through standard of care testing to help understand how well molecular testing might predicts response to therapy. Patient demographic and outcome parameters to be evaluated include, but are not limited to, tumor response, time to treatment failure, patient survival, and toxicity.
CONDITIONS
Official Title
Determining Individualized Cancer Therapy in Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 6518 years
- Pathologically confirmed pancreatic cancer
- Ability to understand a written informed consent document and willingness to sign it
You will not qualify if you...
- Age <18 years
- Primary cancer diagnosis other than pancreatic cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226
Actively Recruiting
Research Team
C
Cancer Center Clinical Trials Office
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here